Literature DB >> 19165445

[Cannabinoids in medicine].

Rita Lenk1, Rudolf Likar.   

Abstract

Cannabinoids have been known for many centuries because of their various effects in healthcare. They are primarily effective in reducing nausea, vomiting, pain, anorexia, spasticity and depression. Some other effects are known, all seem to be mediated by cannabinoid receptors in the central nervous system. In the past years, medical use has been proven in several studies. Today, the therapeutical use of cannabinoids in medicine is increasing, and access was made easier. Especially in pain-management and palliative care, they seem to be a valuable therapeutic option.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19165445     DOI: 10.1007/s10354-008-0619-7

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  18 in total

1.  Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain.

Authors:  Michael Iskedjian; Basil Bereza; Allan Gordon; Charles Piwko; Thomas R Einarson
Journal:  Curr Med Res Opin       Date:  2007-01       Impact factor: 2.580

2.  Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.

Authors:  J P Zajicek; H P Sanders; D E Wright; P J Vickery; W M Ingram; S M Reilly; A J Nunn; L J Teare; P J Fox; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

3.  A multicenter dose-escalation study of the analgesic and adverse effects of an oral cannabis extract (Cannador) for postoperative pain management.

Authors:  Anita Holdcroft; Mervyn Maze; Caroline Doré; Susan Tebbs; Simon Thompson
Journal:  Anesthesiology       Date:  2006-05       Impact factor: 7.892

4.  Analgesic effect of delta-9-tetrahydrocannabinol.

Authors:  R Noyes; S F Brunk; D A Baram; A Canter
Journal:  J Clin Pharmacol       Date:  1975 Feb-Mar       Impact factor: 3.126

5.  Anorexia of aging in long term care: is dronabinol an effective appetite stimulant?--a pilot study.

Authors:  M M G Wilson; C Philpot; J E Morley
Journal:  J Nutr Health Aging       Date:  2007 Mar-Apr       Impact factor: 4.075

6.  Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting.

Authors:  Eyal Meiri; Haresh Jhangiani; James J Vredenburgh; Luigi M Barbato; Frederick J Carter; Hwa-Ming Yang; Vickie Baranowski
Journal:  Curr Med Res Opin       Date:  2007-03       Impact factor: 2.580

7.  [Delta(9)-tetrahydrocannabinol and the opioid receptor agonist piritramide do not act synergistically in postoperative pain].

Authors:  W Seeling; L Kneer; B Büchele; J E Gschwend; L Maier; C Nett; T Simmet; P Steffen; M Schneider; M Rockemann
Journal:  Anaesthesist       Date:  2006-04       Impact factor: 1.041

8.  The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS).

Authors:  R M Freeman; O Adekanmi; M R Waterfield; A E Waterfield; D Wright; J Zajicek
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-03-22

Review 9.  [Review of cannabinoids in the treatment of nausea and vomiting].

Authors:  L Radbruch; F Nauck
Journal:  Schmerz       Date:  2004-08       Impact factor: 1.107

Review 10.  [Use and effectiveness of dronabinol (delta9-tetrahydrocannabinol) in chronic pain].

Authors:  B Gauter; R Rukwied; C Konrad
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.